tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AQST Stock Latest News

Aquestive Therapeutics Outlines Growth and Product Progress
Company AnnouncementsAquestive Therapeutics Outlines Growth and Product Progress
11d ago
8K
AQST
Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th
PremiumPress Releases
Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th
11d ago
AQST
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
PremiumPress Releases
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
29d ago
AQST
Aquestive Therapeutics reiterates expected timing for NDA filing of Anaphylm
PremiumThe Fly
Aquestive Therapeutics reiterates expected timing for NDA filing of Anaphylm
1M ago
AQST
Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™
PremiumPress Releases
Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™
1M ago
AQST
Aquestive Therapeutics price target raised to $15 from $13 at Oppenheimer
PremiumThe FlyAquestive Therapeutics price target raised to $15 from $13 at Oppenheimer
1M ago
AQST
SPRY
Aquestive Therapeutics Unveils Investor Presentation Update
Premium
Company Announcements
Aquestive Therapeutics Unveils Investor Presentation Update
1M ago
8K
AQST
Aquestive Therapeutics raises 2024 revenue outlook to $57M-$60M from $48M-$51M
Premium
The Fly
Aquestive Therapeutics raises 2024 revenue outlook to $57M-$60M from $48M-$51M
1M ago
AQST
Aquestive Therapeutics reports Q2 EPS (3c), consensus (12c)
PremiumThe Fly
Aquestive Therapeutics reports Q2 EPS (3c), consensus (12c)
1M ago
AQST
AQST Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AQST Upcoming Earnings Report: What to Expect?
2M ago
AQST
Aquestive Therapeutics Advances Non-Invasive Epinephrine Treatment
PremiumCompany Announcements
Aquestive Therapeutics Advances Non-Invasive Epinephrine Treatment
2M ago
8K
AQST
Aquestive Therapeutics reports data for Anaphylm Sublingual Film
PremiumThe Fly
Aquestive Therapeutics reports data for Anaphylm Sublingual Film
2M ago
AQST
Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study
PremiumPress ReleasesAquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study
2M ago
AQST
Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET
Premium
Press Releases
Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET
2M ago
AQST
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Premium
Press Releases
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
3M ago
AQST
Aquestive reports topline data from temperature/pH study of Anaphylm
PremiumThe Fly
Aquestive reports topline data from temperature/pH study of Anaphylm
3M ago
AQST
Aquestive Therapeutics to join Russell 3000, Russell 2000 Indexes
PremiumThe Fly
Aquestive Therapeutics to join Russell 3000, Russell 2000 Indexes
3M ago
AQST
Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
PremiumPress Releases
Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
3M ago
AQST
Aquestive Therapeutics Shares Investor Presentation Update
PremiumCompany Announcements
Aquestive Therapeutics Shares Investor Presentation Update
3M ago
8K
AQST
Aquestive Therapeutics Appoints Cassie Jung as COO
PremiumCompany AnnouncementsAquestive Therapeutics Appoints Cassie Jung as COO
4M ago
8K
AQST
Aquestive Therapeutics appoints Cassie Jung as COO, Stephen Wargacki as CSO
Premium
The Fly
Aquestive Therapeutics appoints Cassie Jung as COO, Stephen Wargacki as CSO
4M ago
AQST
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
Premium
Press Releases
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
4M ago
AQST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >